Cosmos Health (NASDAQ:COSM) Shares Up 0.1% – Here’s Why
by Scott Moore · The Cerbat GemCosmos Health Inc. (NASDAQ:COSM – Get Free Report)’s stock price shot up 0.1% during trading on Tuesday . The company traded as high as $0.3367 and last traded at $0.3073. 1,210,134 shares traded hands during mid-day trading, a decline of 25% from the average session volume of 1,618,328 shares. The stock had previously closed at $0.3069.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.
Get Our Latest Research Report on Cosmos Health
Cosmos Health Stock Performance
The stock has a market capitalization of $16.08 million, a P/E ratio of -0.50 and a beta of 5.00. The firm has a 50-day moving average of $0.35 and a 200 day moving average of $0.48. The company has a quick ratio of 0.85, a current ratio of 1.00 and a debt-to-equity ratio of 0.32.
Insider Buying and Selling at Cosmos Health
In other Cosmos Health news, CEO Grigorios Siokas bought 388,532 shares of the stock in a transaction dated Thursday, February 12th. The stock was bought at an average cost of $0.37 per share, for a total transaction of $143,756.84. Following the completion of the purchase, the chief executive officer owned 8,861,914 shares in the company, valued at $3,278,908.18. This represents a 4.59% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 25.10% of the company’s stock.
Institutional Trading of Cosmos Health
Hedge funds and other institutional investors have recently made changes to their positions in the business. XTX Topco Ltd increased its position in Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares during the period. Renaissance Technologies LLC raised its position in shares of Cosmos Health by 260.5% in the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after acquiring an additional 241,775 shares during the period. Finally, Citadel Advisors LLC raised its position in shares of Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after acquiring an additional 128,776 shares during the period. 12.61% of the stock is currently owned by institutional investors and hedge funds.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.